Anticancer agent 353
Anticancer agent 353 is a heterobifunctional antitumor agent with weak ERα inhibitory activity and anticancer activity. Anticancer agent 353 exhibits growth inhibitory activity against MCF7 cells. Anticancer agent 353 can be used in cancer research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 3099598-10-1
- Formule: C52H58N8OS
- Masse moléculaire:843.13
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
ERα |
Anticancer agent 353 (III-146) exhibits growth inhibitory activity against MCF7 cells, with a GI50 of < 0.05 μM[1].
Anticancer agent 353 exhibits activity in both Doxorubicin (HY-15142A)-induced ERα-overexpressing and non-induced T-Rex 293 cells, with consistent antiproliferative activity between the two groups (GI50 = 0.5-2.5 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 3099598-10-1
-
Masse moléculaire 843.13
-
Formule C52H58N8OS
-
SMILES
OC1=CC=C([C@@H](C2=CC=C(N3CC(C3)CN4CCN(CC4)CC5CN(C6=CC=C(C7=N[C@H](C)C8=NN=C(C)N8C9=C7C(C)=C(C)S9)C=C6)C5)C=C2)[C@@H](C%10=CC=CC=C%10)CC%11)C%11=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)